Purchase Order W81K0023P0048
Award Date 4/17/23
Potential Completion Date 4/16/28
Potential Value $108K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Irwin, CA 92310, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency, operating under the Defense Department's Medical Supply Chain, awarded a delivery order valued at $1,037.23 to Ortho-Clinical Diagnostics, Inc. on January 7, 2026, for Anti-D Bioclone 150ML monoclonal antibodies used in blood bank operations. The contract utilizes a firm fixed-price structure with a completion date of January 8, 2026, and was procured through open competition with no set-aside designation. Performance will occur at Ortho-Clinical Diagnostics'...
- The Defense Health Agency awarded a $85.5K firm fixed-price purchase order to Ortho-Clinical Diagnostics, Inc. for blood supplies, specifically blood type testing reagents (MTS A/B/D monoclonal and reverse group testing kits in 5x20 unit configurations). The contract was awarded on October 1, 2020, with an ultimate completion date of September 27, 2021, and involves performance at Ortho-Clinical Diagnostics' facility in Raritan, New Jersey. This procurement utilized open competition with no...
- The Defense Health Agency awarded a purchase order valued at $106,717.41 to Ortho-Clinical Diagnostics, Inc. for ortho-clinical blood analyzer reagents and optical equipment, with a performance location at Fort Drum, New York. The contract, awarded on November 21, 2023, utilizes firm fixed price pricing and is structured as a standard purchase order with no set-aside designation. The ultimate completion date is November 20, 2028, providing a multi-year supply arrangement for critical...
- The Defense Health Agency awarded a delivery order valued at $641,516.80 to Ortho-Clinical Diagnostics, Inc. for reagents and consumables to support laboratory operations at Fort Belvoir, Virginia. This firm fixed-price delivery order, issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule, carries an ultimate completion date of April 30, 2030, and represents an open competition contract with no set-aside designation. Ortho-Clinical Diagnostics, a medical equipment...
- The Defense Health Agency awarded a $85,482.80 firm fixed-price purchase order to Ortho-Clinical Diagnostics, Inc. for MTS A/B/D Mono & Reverse Group 5x20 products on October 1, 2022, with a completion deadline of September 26, 2023. The solicitation, posted on September 23, 2022 with a due date of September 28, 2022, sought these specialized diagnostic reagents and related supplies without set-aside designation, reflecting open competition procurement. Performance of this contract is taking...
- The Defense Medical Supply Chain awarded a delivery order to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10mL, a blood bank reagent product, with a fixed-price ceiling value of $1,156.61. The award was issued on November 7, 2025, with an ultimate completion date of November 13, 2025. This delivery order was issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule, a governmentwide acquisition vehicle that streamlines procurement of...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $2,074.46 by the Defense Health Agency's Medical Supply Chain on August 5, 2025, for the supply of Rh antigen anti-D blood bank reagent in 150ml monoclonal ABO group format. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance is scheduled for completion by August 8, 2025, at the contractor's facility in Raritan, New Jersey. This delivery order represents a...
- Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer headquartered in Raritan, New Jersey, was awarded a firm fixed-price purchase order by the Medical Command (Defense) on October 1, 2019, for blood bank reagents and related supplies. The contract, which carries a ceiling value of $593,524.45 and was executed at Fort Stewart, Georgia, encompasses a base year and an option year 2 period, with an ultimate completion date of September 30, 2024. This award was issued...
- Ortho-Clinical Diagnostics, Inc. was awarded a $106,667.83 delivery order for automated blood grouping equipment and services by the Defense Health Agency on September 28, 2021, with a completion date of September 27, 2023. This firm fixed-price contract, which utilized no set-aside designation, represents a task order under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The work is to be performed at the contractor's facility in Raritan, New...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a Blanket Purchase Agreement (BPA) call valued at $12,179.85 on December 3, 2025, for reagents for blood testing. The Defense Health Agency, under the Department of Defense, funded this award. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by September 30, 2026. This award represents a delivery order against an existing BPA vehicle, leveraging the General...